Docality.com Logo
 
Dr. Nighat  Sarwar  Md image

Dr. Nighat Sarwar Md

1313 E Herndon Ave Suite 205
Fresno CA 93720
559 350-0311
Medical School: Other - 1987
Accepts Medicare: Yes
Participates In eRX: No
Participates In PQRS: Yes
Participates In EHR: No
License #: A71634
NPI: 1003809989
Taxonomy Codes:
2084N0400X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Dr. Nighat Sarwar is associated with these group practices

Procedure Pricing

HCPCS Code Description Average Price Average Price
Allowed By Medicare
HCPCS Code:J3488 Description:Reclast injection Average Price:$713.60 Average Price Allowed
By Medicare:
$223.83
HCPCS Code:96365 Description:Ther/proph/diag iv inf init Average Price:$250.00 Average Price Allowed
By Medicare:
$76.91
HCPCS Code:96413 Description:Chemo iv infusion 1 hr Average Price:$300.00 Average Price Allowed
By Medicare:
$147.03
HCPCS Code:99204 Description:Office/outpatient visit new Average Price:$264.83 Average Price Allowed
By Medicare:
$167.26
HCPCS Code:J1745 Description:Infliximab injection Average Price:$151.60 Average Price Allowed
By Medicare:
$64.26
HCPCS Code:96415 Description:Chemo iv infusion addl hr Average Price:$99.87 Average Price Allowed
By Medicare:
$32.33
HCPCS Code:95860 Description:Muscle test one limb Average Price:$150.00 Average Price Allowed
By Medicare:
$104.16
HCPCS Code:95934 Description:H-reflex test Average Price:$101.14 Average Price Allowed
By Medicare:
$69.70
HCPCS Code:J0897 Description:Denosumab injection Average Price:$45.36 Average Price Allowed
By Medicare:
$14.37
HCPCS Code:95903 Description:Motor nerve conduction test Average Price:$105.00 Average Price Allowed
By Medicare:
$80.63
HCPCS Code:95904 Description:Sense nerve conduction test Average Price:$85.00 Average Price Allowed
By Medicare:
$61.35
HCPCS Code:99214 Description:Office/outpatient visit est Average Price:$130.41 Average Price Allowed
By Medicare:
$109.77
HCPCS Code:99215 Description:Office/outpatient visit est Average Price:$164.63 Average Price Allowed
By Medicare:
$147.61
HCPCS Code:95900 Description:Motor nerve conduction test Average Price:$85.00 Average Price Allowed
By Medicare:
$69.39
HCPCS Code:36415 Description:Routine venipuncture Average Price:$13.08 Average Price Allowed
By Medicare:
$3.00
HCPCS Code:96372 Description:Ther/proph/diag inj sc/im Average Price:$35.00 Average Price Allowed
By Medicare:
$25.43
HCPCS Code:J7050 Description:Normal saline solution infus Average Price:$8.00 Average Price Allowed
By Medicare:
$0.28
HCPCS Code:J2323 Description:Natalizumab injection Average Price:$15.48 Average Price Allowed
By Medicare:
$11.35
HCPCS Code:99213 Description:Office/outpatient visit est Average Price:$74.60 Average Price Allowed
By Medicare:
$71.99
HCPCS Code:Q0138 Description:Ferumoxytol, non-esrd Average Price:$2.57 Average Price Allowed
By Medicare:
$0.64
HCPCS Code:96374 Description:Ther/proph/diag inj iv push Average Price:$50.00 Average Price Allowed
By Medicare:
$50.00

HCPCS Code Definitions

95860
Needle electromyography; 1 extremity with or without related paraspinal areas
96365
Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96372
Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular
96374
Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug
96413
Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415
Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
99204
Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 45 minutes are spent face-to-face with the patient and/or family.
99213
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: An expanded problem focused history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 15 minutes are spent face-to-face with the patient and/or family.
99214
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A detailed history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 25 minutes are spent face-to-face with the patient and/or family.
99215
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 40 minutes are spent face-to-face with the patient and/or family.
J0897
Injection, denosumab, 1 mg
J1745
Injection infliximab, 10 mg
J2323
Injection, natalizumab, 1 mg
J3488
Injection, zoledronic acid (reclast), 1 mg
J7050
Infusion, normal saline solution , 250 cc
Q0138
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

NPI
Doctor Name
Specialty
Count
1538244314
Hematology/Oncology
1,819
1679612436
Internal Medicine
1,532
1447238936
Family Practice
984
1346349065
Physical Medicine And Rehabilitation
925
1811912348
Neurology
734
1356360887
Cardiovascular Disease (Cardiology)
701
1336287440
Internal Medicine
637
1669560041
Ophthalmology
533
1508862566
Diagnostic Radiology
516
1790780658
Urology
511
*These referrals represent the top 10 that Dr. Sarwar has made to other doctors

Publications

Evaluation of Bt-cotton Genotypes for Resistance to Cotton Leaf Curl Disease under High Inoculum Pressure in the Field and Using Graft Inoculation in Glasshouse. - The plant pathology journal
Bt-cotton germplasm, consisting of 75 genotypes was evaluated against cotton leaf curl disease (CLCuD) under high inoculum pressure in the field and using graft inoculation in glasshouse by visual symptom scoring assessments. None of the tested genotype was found disease free under both evaluation tests. Under field conditions in 2011, 3 genotypes were found resistant, 4 moderately resistant, 3 tolerant, 2 moderately susceptible and one susceptible; in 2012, 3 genotypes were tolerant, 7 moderately susceptible, 5 susceptible and 38 highly susceptible; in 2013, one was moderately susceptible and 51 were highly susceptible with varying degree of percent disease index (PDI) and severity index (SI). However, through graft evaluation in glasshouse, none of the graft inoculated plant was symptomless. All tested genotypes showed disease symptoms with SI values ranging between 5.0 and 6.0, and latent period between 12 and 14 days. Of the 75 genotypes evaluated using graft inoculation, 11 were found susceptible with SI values of 5.0 to 5.4 while remaining 64 were highly susceptible with SI values of 5.5 to 6.0. Inoculated plants of all tested genotypes exhibited severe disease symptoms within 10 days after the appearance of initial symptoms. No reduction in SI value was observed until the end of the experiment i.e., 90 days after grafting. Information generated under the present study clearly demonstrates that no sources of resistance to CLCuD are available among the tested Bt-cotton genotypes. So, a breeding programme is needed to introgress the CLCuD-resistance from other resistant sources to agronomically suitable Bt-cotton genotypes.

Map & Directions

1313 E Herndon Ave Suite 205 Fresno, CA 93720
View Directions In Google Maps

Nearby Doctors

7300 N Fresno St
Fresno, CA 93720
559 484-4500
1570 E Herndon Ave
Fresno, CA 93720
559 377-7300
7750 N Fresno St Ste 105
Fresno, CA 93720
559 380-0121
2509 E Cole Ave
Fresno, CA 93720
559 237-7120
1642 E Herndon Ave Suite 103
Fresno, CA 93720
559 398-8642
7565 N Cedar Ave Suite 101
Fresno, CA 93720
559 388-8888
7942 N Maple #109
Fresno, CA 93720
559 980-0124
1303 E Herndon Ave
Fresno, CA 93720
559 503-3000
7415 N Cedar Ave Suite 102
Fresno, CA 93720
559 355-5200
1303 E Herndon Ave
Fresno, CA 93720
559 495-5360